Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Graham

Showing results (801-810 of 840) with videos related to

Pageof 84
Sort By:
The Lancet. Digital Health|March 6, 2020
Development and validation of a risk prediction model to diagnose Barrett's oesophagus (MARK-BE): a case-control machine learning approachAvi Rosenfeld, David G Graham, Sarah Jevons, et al.
Biochemical Pharmacology|December 9, 2009
Acetaminophen (paracetamol) inhibits myeloperoxidase-catalyzed oxidant production and biological damage at therapeutically achievable concentrationsMaud Koelsch, Roger Mallak, Garry G Graham, et al.
ACS Infectious Diseases|July 10, 2023
Polyunsaturated Fatty Acid-Derived Lipid Mediators as Potential Biomarkers for Leprosy Among Individuals with Asymptomatic <i>Mycobacterium leprae</i> InfectionCarlos A M Silva, Barbara G Graham, Kristofor Webb, et al.
Annals of the Rheumatic Diseases|August 14, 2014
Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysinWen-Hung Chung, Wan-Chun Chang, Sophie L Stocker, et al.
Annals of Neurology|May 1, 1997
Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repeat expansionL Montermini, A Richter, K Morgan, et al.
Journal of Medicinal Chemistry|March 14, 1997
Effect of structural modification of enol-carboxamide-type nonsteroidal antiinflammatory drugs on COX-2/COX-1 selectivityE S Lazer, C K Miao, C L Cywin, et al.
Antimicrobial Agents and Chemotherapy|August 9, 2021
Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832Gregory T Robertson, Michelle E Ramey, Lisa M Massoudi, et al.
Nature Communications|September 29, 2025
Post-resection delivery of a TLR7/8 agonist from a biodegradable scaffold achieves immune-mediated glioblastoma clearance and protection against tumor challenge in miceElizabeth G Graham-Gurysh, Ryan N Woodring, Sean R Simpson, et al.
Cell Death & Disease|December 20, 2025
Targeting secreted PLA<sub>2</sub> interactions with EGFR and vimentin to arrest prostate tumour growthTimothy J Mann, Ryung Rae Kim, Mila Sajinovic, et al.
Frontiers in Medicine|April 24, 2023
A retrospective analysis of normal saline and lactated ringers as resuscitation fluid in sepsisShahin Isha, Parthkumar H Satashia, Siva Naga S Yarrarapu, et al.
Pageof 84

Showing results (801-810 of 840) with videos related to

Sort By:
Pageof 84
The Lancet. Digital Health|March 6, 2020
Development and validation of a risk prediction model to diagnose Barrett's oesophagus (MARK-BE): a case-control machine learning approachAvi Rosenfeld, David G Graham, Sarah Jevons, et al.
Biochemical Pharmacology|December 9, 2009
Acetaminophen (paracetamol) inhibits myeloperoxidase-catalyzed oxidant production and biological damage at therapeutically achievable concentrationsMaud Koelsch, Roger Mallak, Garry G Graham, et al.
ACS Infectious Diseases|July 10, 2023
Polyunsaturated Fatty Acid-Derived Lipid Mediators as Potential Biomarkers for Leprosy Among Individuals with Asymptomatic <i>Mycobacterium leprae</i> InfectionCarlos A M Silva, Barbara G Graham, Kristofor Webb, et al.
Annals of the Rheumatic Diseases|August 14, 2014
Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysinWen-Hung Chung, Wan-Chun Chang, Sophie L Stocker, et al.
Annals of Neurology|May 1, 1997
Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repeat expansionL Montermini, A Richter, K Morgan, et al.
Journal of Medicinal Chemistry|March 14, 1997
Effect of structural modification of enol-carboxamide-type nonsteroidal antiinflammatory drugs on COX-2/COX-1 selectivityE S Lazer, C K Miao, C L Cywin, et al.
Antimicrobial Agents and Chemotherapy|August 9, 2021
Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832Gregory T Robertson, Michelle E Ramey, Lisa M Massoudi, et al.
Nature Communications|September 29, 2025
Post-resection delivery of a TLR7/8 agonist from a biodegradable scaffold achieves immune-mediated glioblastoma clearance and protection against tumor challenge in miceElizabeth G Graham-Gurysh, Ryan N Woodring, Sean R Simpson, et al.
Cell Death & Disease|December 20, 2025
Targeting secreted PLA<sub>2</sub> interactions with EGFR and vimentin to arrest prostate tumour growthTimothy J Mann, Ryung Rae Kim, Mila Sajinovic, et al.
Frontiers in Medicine|April 24, 2023
A retrospective analysis of normal saline and lactated ringers as resuscitation fluid in sepsisShahin Isha, Parthkumar H Satashia, Siva Naga S Yarrarapu, et al.
Pageof 84